Zvi G. Fridlender

Resistance to adjuvant arthritis is due to protective antibodies against heat shock protein surface epitopes and the induction of IL-10 secretion.

Pleural effusion.

Metastatic carcinoma presenting with concomitant eosinophilia and thromboembolism.

Myocardial infarction in a patient with beta-thalassemia major: first report.

Recurrent infusion phlebitis induced by cyclosporine.

Obstructing tracheal pulmonary Langerhans cell histiocytosis.

Late-onset sarcoidosis after liver transplantation for primary biliary cirrhosis.

Association between cytomegalovirus infection and venous thromboembolism.

B-cell depletion using an anti-CD20 antibody augments antitumor immune responses and immunotherapy in nonhematopoetic murine tumor models.

Bronchoscopy in octogenarians.

Systemic blockade of transforming growth factor-beta signaling augments the efficacy of immunogene therapy.

The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer.

Evaluation of an attenuated vesicular stomatitis virus vector expressing interferon-beta for use in malignant pleural mesothelioma: heterogeneity in interferon responsiveness defines potential efficacy.

Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN.

Expression of IFN-beta enhances both efficacy and safety of oncolytic vesicular stomatitis virus for therapy of mesothelioma.

CCL2 blockade augments cancer immunotherapy.

Activation of the nucleotide oligomerization domain signaling pathway by the non-bacterially derived xanthone drug 5'6-dimethylxanthenone-4-acetic acid (Vadimezan).

Monocyte chemoattractant protein-1 blockade inhibits lung cancer tumor growth by altering macrophage phenotype and activating CD8+ cells.

Association between CD14 gene polymorphisms and disease phenotype in sarcoidosis.

Chemotherapy delivered after viral immunogene therapy augments antitumor efficacy via multiple immune-mediated mechanisms.

Pharmacologic activation of the innate immune system to prevent respiratory viral infections.

Sildenafil to facilitate weaning from inhaled nitric oxide and mechanical ventilation in a patient with severe secondary pulmonary hypertension and a patent foramen ovale.

Activation of mitogen-activated protein kinases by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) plays an important role in macrophage stimulation.

Treating tumors with a vaccinia virus expressing IFNβ illustrates the complex relationships between oncolytic ability and immunogenicity.

Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophils.

Tumor-associated neutrophils: friend or foe?

Characterization of surgical models of postoperative tumor recurrence for preclinical adjuvant therapy assessment.

A positive-margin resection model recreates the postsurgical tumor microenvironment and is a reliable model for adjuvant therapy evaluation.

Randomized controlled crossover trial of a new oscillatory device as add-on therapy for COPD.

Modifying tumor-associated macrophages: An important adjunct to immunotherapy.

Neutrophils recruit regulatory T-cells into tumors via secretion of CCL17--a new mechanism of impaired antitumor immunity.

The Multifaceted Roles Neutrophils Play in the Tumor Microenvironment.

Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer.

Surgical cytoreduction restores the antitumor efficacy of a Listeria monocytogenes vaccine in malignant pleural mesothelioma.